BACKGROUND: Dystrophic calcinosis cutis is a common manifestation in connective tissue diseases, but there’s still no consensus on treatment. OBJECTIVES. Abstract. Objectives: To evaluate the effect of minocycline as treatment for cutaneous . Calcinosis cutis circumscripta: treatment with intralesional corticosteroid. An year-old woman was followed up for a year history of limited cutaneous systemic sclerosis complicated by recurrent subcutaneous lesions of calcinosis.

Author: Meztit Kazikree
Country: Cameroon
Language: English (Spanish)
Genre: Travel
Published (Last): 25 February 2013
Pages: 489
PDF File Size: 3.11 Mb
ePub File Size: 13.67 Mb
ISBN: 837-6-72698-840-5
Downloads: 29341
Price: Free* [*Free Regsitration Required]
Uploader: Mazugami

Pharmacological treatment in calcinosis cutis associated with connective-tissue diseases.

For larger lesions, drugs that may help include:. Depending on the underlying cause, a multidisciplinary team of physicians including nephrologist, rheumatologist, and haematologist may be needed to manage the condition. Calcific tendonitis is one of the most common causes of shoulder pain. The doctor will likely order several laboratory tests to determine the underlying cause of your calcinosis cutis:.

It can also predict the disease progression. The signs and symptoms of calcinosis cutis vary according to the underlying cause. Determining the type of calcinosis cutis you have is important in deciding the appropriate treatment. In rare cases, a lesion may become life-threatening. Conditions that can cause dystrophic calcinosis cutis include:.


They start slowly and vary in size. These range from infection and injury to systemic diseases like kidney failure. Current treatments may help, and new therapies are being developed. Biopsy of cutaneous lesions is used to confirm diagnosis. Your Questions Answered Infrared saunas promise a number of health benefits, from weight loss and decreased stress levels to improved circulation and even better skin.

Medications that may be tried include corticosteroids, probenecid, colchicine, sodium etidronate, diphosphonates, diltiazem, and magnesium and aluminium antacids. Causes of the abnormal levels of calcium and phosphate are:.

The new options available in the management of calcinosis cutis, like biological therapies or intravenous immunoglobulin, seem cufis be promising, but not universally successful. A new technology under development to aid diagnosis is advanced vibrational spectroscopy. Causes of calcinosis cutis. Approximately 1 in 6 U. The underlying cause of calcinosis cutis should be identified and treated accordingly.

Conditions that can cause metastatic ccutis cutis include:. Recurrence is common after excision. Some of the procedures involved are:.

Calcinosis cutis is classified into four major types. Treatments are available, including surgery, but the calcium lesions may recur.


It seems to be efficient in more than half of the reported cases. Calcification Calcification calcibosis when calcium builds up in areas of body tissue where calcium normally doesn’t exist.

An estimated calcniosis to 40 percent of those with CREST syndrome will develop calcinosis cutis after 10 years. Normal serum calcium and phosphate levels exist. Diagnosis of calcinosis cutis.

Pharmacological treatment in calcinosis cutis associated with connective-tissue diseases.

The outlook for calcinosis cutis depends on its underlying disease or cause, and the severity of your lesions. Trsatment remain, however, a significant number of patients in which another solution must be found.

The general trends observed over time are of switching the search of solutions in dystrophic calcinosis cutis related to connective tissue diseases, from therapies on calcium metabolism to therapies for the underlying disease. Calcification occurs when calcium builds up in areas of body cutjs where calcium normally doesn’t exist.